$BLZE Balance Sheet | Understand Stock

$BLZE

$9.31 +$0.06 (0.65%) After hours

$BLZE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Restricted cash, current
Short-term investments, net
Prepaid expenses and other current assets
Prepaid expenses
Other current assets
Total current assets
Restricted cash, non-current
Property and equipment, net
Operating lease right-of-use assets, net
Capitalized internal-use software, net
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Accrued value-added tax (“VAT”) liability
Debt facility, current
Accounts payable, accrued expenses and other current liabilities
Finance lease liabilities and lease financing obligations, current
Operating lease liabilities, current
Deferred revenue, current
Total current liabilities
Finance lease liabilities and lease financing obligations, non-current
Operating lease liabilities, non-current
Deferred revenue, non-current and other liabilities, non-current
Other long-term liabilities
Simple agreement for future equity (“SAFE”) notes
Debt facility, non-current
Deferred revenue and other liabilities, non-current
Total liabilities
Convertible preferred stock, $0.0001 and $0.001 par value as of December 31, 2021 and 2020; 10,000,000 and 9,000,000 shares authorized as of December 31, 2021 and 2020, respectively; zero and 3,359,195 shares issued and outstanding with no aggregate liquidation preference and $2,852 as of December 31, 2021 and 2020, respectively.
Stockholders’ Equity
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized as of June 30, 2026 and December 31, 2025; zero shares issued and outstanding as of June 30, 2026 and December 31, 2025
Class A common stock
Total preferred Stock, $0.0001 par value; 10,000,000 shares authorized as of June 30, 2026 and December 31, 2025; zero shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, value, issued
Class A common stock
Class B common stock
Total common stock, value, issued

Treasury stock, at cost; 256,549 and zero shares as of December 31, 2025 and 2024, respectively
Treasury stock, at cost; 570,814 and 256,549 shares as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Common stock, authorized (in shares)
Class A common stock
Class B common stock
Total common stock, authorized (in shares)

Comments